...
首页> 外文期刊>Journal of Clinical Microbiology >Multicenter Clinical Evaluation of VRESelect Agar for Identification of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium
【24h】

Multicenter Clinical Evaluation of VRESelect Agar for Identification of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium

机译:VRESelect琼脂鉴定耐万古霉素的粪肠球菌和粪肠球菌的多中心临床评价

获取原文
           

摘要

A chromogenic medium for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, VRESelect, was compared to bile esculin azide agar with 6 μg/ml vancomycin (BEAV) for the isolation of vancomycin-resistant enterococci (VRE) from stool specimens. At 24 to 28 h, VRESelect demonstrated 98.7% (confidence interval [CI], 96.1 to 99.7%) sensitivity and 99.0% (CI, 98.0 to 99.6%) specificity versus 85.1% (CI, 79.8 to 89.5%) and 90.1% (CI, 79.8 to 89.5%) sensitivity and specificity, respectively, for BEAV.
机译:将用于鉴定耐万古霉素的粪肠球菌和粪肠球菌的发色培养基VRESelect与具有6μg/ ml万古霉素(BEAV)的胆汁叠氮化物琼脂进行比较,以从粪便标本中分离出耐万古霉素的肠球菌(VRE)。在24至28小时时,VRESelect表现出98.7%(置信区间[CI],96.1至99.7%)敏感性和99.0%(CI,98.0至99.6%)特异性,而85.1%(CI,79.8至89.5%)和90.1%(CI) CI对BEAV的敏感性和特异性分别为79.8至89.5%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号